{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:58:08Z","timestamp":1793973488463,"version":"4.8.0"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T00:00:00Z","timestamp":1326067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background\/Aims<\/jats:title><jats:p>The upper gastrointestinal (<jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>) toxicity associated with non\u2010steroidal anti\u2010inflammatory drugs (<jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>) use among cirrhotic patients remains unclear. The objective of this study was to evaluate the risk of upper <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content> adverse events associated with celecoxib and oral and parenteral non\u2010selective <jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>s in cirrhotic patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All the patients aged \u2265\u00a020\u00a0years with a diagnosis of cirrhosis hospitalized for variceal bleeding and non\u2010variceal upper <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content> adverse events (oesophageal, gastric, duodenal ulcer, bleeding; gastritis and duodenitis) in 2006 were identified using <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\u20109\u2010<jats:styled-content style=\"fixed-case\">CM<\/jats:styled-content> diagnosis codes from inpatient claims from the Taiwan National Health Insurance Database. In the case\u2010crossover study design, the case period was defined as 1\u201330\u00a0days and the control period as 31\u201360\u00a0days before the date of hospitalization. The information for individual <jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content> use was obtained from the outpatient pharmacy prescription database. Adjusted self\u2010matched odds ratios (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>) and their 95% confidence intervals (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) were estimated with a conditional logistic regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 4876 cirrhotic patients were included. The adjusted <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) was 1.44 (0.89\u20132.31) for celecoxib, 1.87 (1.66\u20132.11) for oral non\u2010selective <jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>s and 1.90 (1.55\u20132.32) for parenteral <jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>s overall. Risks were similar for variceal and non\u2010variceal events. Concomitant use of proton pump inhibitors and histamine\u20102 receptor antagonists tended to decrease the upper <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content> toxicity associated with non\u2010selective <jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>s and celecoxib.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of ns<jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>s but not celecoxib was associated with a two\u2010fold increased risk of variceal and non\u2010variceal upper <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content> events among cirrhotic patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1478-3231.2011.02739.x","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T05:28:05Z","timestamp":1326086885000},"page":"859-866","source":"Crossref","is-referenced-by-count":50,"title":["Non\u2010steroidal anti\u2010inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients"],"prefix":"10.1111","volume":"32","author":[{"given":"Yen\u2010Chieh","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Family Medicine Cathay General Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia\u2010Hsuin","family":"Chang","sequence":"additional","affiliation":[{"name":"Institute of Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan"},{"name":"Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jou\u2010Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"Cardiovascular Center National Taiwan University Hospital Yun\u2010Lin Branch Dou\u2010Liou City Yun\u2010Lin Taiwan"},{"name":"Department of Medicine College of Medicine National Taiwan University Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi\u2010Chieh","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min\u2010Shung","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine Cathay General Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei\u2010Shu","family":"Lai","sequence":"additional","affiliation":[{"name":"Institute of Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000155133.50562.c9"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(01)68827-5","article-title":"Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis","volume":"32","author":"del Olmo JA","year":"2000","journal-title":"J Hepatol"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50385"},{"key":"e_1_2_6_5_1","first-page":"1528","article-title":"Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study","volume":"89","author":"Gatta A","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03376.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07294.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440340047004"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02020.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.10.1247"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.03.011"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.038"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2008.07.007"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.229906"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2140"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.21.1.193"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(199710)6:3 <S51::AID-PDS301>3.0.CO;2-S"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03572.x"},{"key":"e_1_2_6_20_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.Defined daily dose: definition and general considerations. Available fromhttp:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/ accessed 29 March 2010"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0534"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.6.866"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04050.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0901512"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80142-5"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.2.270"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1157\/13083251"},{"key":"e_1_2_6_28_1","first-page":"1366","article-title":"Interactions between anti\u2010ulcer drugs and non\u2010steroidal anti\u2010inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices","volume":"56","author":"Yoshida H","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.14.2093"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27412"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2011.02739.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2011.02739.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T04:22:09Z","timestamp":1698639729000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2011.02739.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1478-3231.2011.02739.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02739.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,9]]}}}